Canada Post Corp Registered Pension Plan Takes Position in Kenvue Inc. (NYSE:KVUE)

Canada Post Corp Registered Pension Plan purchased a new stake in Kenvue Inc. (NYSE:KVUE - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 20,809 shares of the company's stock, valued at approximately $444,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Grove Bank & Trust boosted its holdings in Kenvue by 438.4% in the 4th quarter. Grove Bank & Trust now owns 1,163 shares of the company's stock valued at $25,000 after purchasing an additional 947 shares during the period. Geneos Wealth Management Inc. acquired a new position in shares of Kenvue during the fourth quarter valued at about $29,000. SRS Capital Advisors Inc. lifted its stake in shares of Kenvue by 67.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock valued at $30,000 after buying an additional 571 shares during the period. Fortitude Family Office LLC grew its position in Kenvue by 106.6% during the fourth quarter. Fortitude Family Office LLC now owns 1,506 shares of the company's stock worth $32,000 after buying an additional 777 shares in the last quarter. Finally, Versant Capital Management Inc grew its position in Kenvue by 300.8% during the fourth quarter. Versant Capital Management Inc now owns 1,920 shares of the company's stock worth $41,000 after buying an additional 1,441 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on KVUE. Royal Bank of Canada reiterated a "sector perform" rating and issued a $24.00 price objective on shares of Kenvue in a research report on Monday, February 3rd. Piper Sandler upped their target price on Kenvue from $24.00 to $27.00 and gave the company an "overweight" rating in a research note on Monday, February 24th. Citigroup lifted their price target on shares of Kenvue from $21.00 to $22.00 and gave the stock a "neutral" rating in a research note on Monday, April 14th. UBS Group lowered their price target on shares of Kenvue from $23.00 to $21.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. Finally, Barclays reduced their price objective on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a report on Monday, April 14th. Eight research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, Kenvue currently has a consensus rating of "Hold" and a consensus price target of $24.42.

Kenvue Price Performance

NYSE KVUE traded down $0.74 during trading hours on Monday, reaching $22.66. 3,042,082 shares of the company's stock were exchanged, compared to its average volume of 17,034,111. The firm has a fifty day moving average of $22.91 and a 200-day moving average of $22.41. Kenvue Inc. has a one year low of $17.67 and a one year high of $24.46. The stock has a market cap of $43.47 billion, a PE ratio of 42.75, a price-to-earnings-growth ratio of 2.62 and a beta of 1.02. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $0.26 EPS for the quarter, hitting the consensus estimate of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. On average, equities research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th will be given a $0.205 dividend. This represents a $0.82 annualized dividend and a yield of 3.62%. The ex-dividend date is Wednesday, May 14th. Kenvue's payout ratio is presently 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.